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Introduction
Neuroendocrine tumors in the ampulla of Vater are rare
and account for less than 2% of ampullary malignan-
cies. Most neuroendocrine tumors are carcinoids, and
patients with such tumors usually have a better progno-
sis than patients with conventional adenocarcinoma.1–3
Poorly differentiated endocrine carcinomas (small cell
carcinomas and large cell neuroendocrine carcinomas),
on the other hand, are usually aggressive, and progno-
sis is poor.1 Here, we present a case of coexisting large
cell neuroendocrine carcinoma and conventional ade-
nocarcinoma in the ampulla of Vater, which has not
been previously reported in the literature reviewed.
Case Report
A 70-year-old female with a history of type 2 diabetes
mellitus and hypertension was transferred from a local
hospital due to persistent jaundice and tea-colored
urine for 1 month. Endoscopic retrograde cholan-
giopancreatography performed at the local hospital
showed a tumor in the ampulla of Vater. After admis-
sion to our hospital, gastroduodenal endoscopy showed
a swollen duodenal papilla, and endoscopic retrograde
cholangiography revealed a dilated common bile duct
with a maximal diameter of 1.6 cm. Small filling defects
caused by stones in the common bile duct were found,
and endoscopic sphincterotomy was performed. Small
brown stones were drained out after irrigation, and
biopsy was done over the duodenal papilla. Computed
tomography (CT) of the abdomen also showed a
dilated common bile duct and intrahepatic ducts, but
the presence of any periampullary neoplasm was not
confirmed. No enlarged lymph nodes were seen in
the abdomen.
The patient’s jaundice improved after sphinctero-
tomy and serum bilirubin level dropped. Laboratory
data were as follows: hemoglobin, 10.9 g/dL; white
blood cell count, 4,800/mm3; platelet count, 243,000/
mm3; total bilirubin, 0.5mg/dL (normal, 0.2–1.6
mg/dL); alkaline phosphatase, 208 IU/L (normal,
10–100 IU/L); γ-glutamyl transpeptidase, 450 IU/L
(normal, 4–51IU/L); alanine aminotransferase, 12IU/
L (normal, 0–40 IU/L); aspartate aminotransferase,
*Correspondence to: Dr Shih-Hao Liu, Department of Pathology, Taipei Veterans General Hospital,
201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
E-mail: shliu5@vghtpe.gov.tw ● Received: December 24, 2007 ● Accepted: May 23, 2008
CASE REPORT
Coexistence of Large Cell Neuroendocrine
Carcinoma and Adenocarcinoma of the 
Ampulla of Vater
Shih-Hao Liu*, Shyh-Haw Tsay
Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
We report a case of coexisting poorly differentiated endocrine carcinoma and conventional adenocarcinoma in the
ampulla of Vater. A 70-year-old female had a recent history of symptoms and signs related to obstructive jaundice. An ini-
tial endoscopic biopsy of the ampulla of Vater showed a poorly differentiated endocrine carcinoma in the lamina propria
of duodenal mucosa. The tumor could also be categorized into large cell neuroendocrine carcinoma under the WHO clas-
sification of pulmonary neuroendocrine tumors. The patient underwent Whipple’s operation. After thorough microscopic
examination of the ampulla of Vater, we incidentally found another conventional adenocarcinoma on the inner side of the
duodenal papilla, and the tumor collided with the aforementioned carcinoma. The association of neuroendocrine tumor and
adenocarcinoma has been reported in a few case reports and a small series. We also review the literature concerning
large cell neuroendocrine carcinoma in this area. [J Chin Med Assoc 2008;71(10):536–540]
Key Words: adenocarcinoma, ampulla of Vater, endocrine carcinoma
J Chin Med Assoc • October 2008 • Vol 71 • No 10 537
Carcinoma of the ampulla of Vater
21 IU/L (normal, 5–45 IU/L). Tumor markers (can-
cer antigen 125, cancer antigen 153, cancer antigen
199, α-fetoprotein, carcinoembryonic antigen) tested
during hospitalization were all within normal limits.
Pathologic examination of the endoscopic biopsy
showed a poorly differentiated endocrine carcinoma.
The patient was then referred to our surgery depart-
ment. She underwent Whipple’s operation and a cir-
cumferential soft tissue tumor measuring about 1× 1 cm
was found in the ampulla of Vater. The common bile
duct and pancreas were not involved by the tumor. The
operation was smooth, and the patient’s recovery was
uneventful. She was discharged on postoperative day 31.
On hematoxylin and eosin stain, a whole-mount
section of the resected specimen demonstrated the
tumor location (Figure 1A). Sections of the ampulla
of Vater showed tumor cells in nested and organoid
patterns with peripheral palisading; hyperchromatic
and pleomorphic tumor cells with frequent mitoses
and glandular differentiation infiltrated the lamina
propria and muscularis propria of the duodenum
(Figure 1B). The nuclei were vesicular and contained
coarsely granular chromatin and prominent nucleoli.
Multinucleated giant tumor cells were occasionally
seen. Tumor necrosis and lymphovascular invasion were
also noted focally. The tumor cells were immunoreac-
tive for cytokeratin, CD56, chromogranin, and synap-
tophysin (Figure 2). The Ki-67 labeling index was over
90%. The common bile duct and pancreas were not
involved by the tumor as observed under gross inspec-
tion. All sampled lymph nodes and surgical cut ends
were free of tumor involvement. Therefore, our diag-
nosis of the tumor was poorly differentiated endocrine
carcinoma.
In addition, after thorough microscopic examina-
tion of the ampulla of Vater, a 0.6-cm conventional duc-
tal adenocarcinoma composed of infiltrating glands
was seen on the inner side of the duodenal papilla
(Figure 1C). Some neoplastic glands were abortive
and had prominent nuclear atypia. There was low-
grade to high-grade dysplastic epithelium adjacent to
the adenocarcinoma. The aforementioned poorly dif-
ferentiated endocrine carcinoma extended to this area
and collided with the ductal adenocarcinoma (Figure
1D). Compared with the immunoprofiles of the
poorly differentiated carcinoma, the ductal adenocar-
cinoma was negative for neuroendocrine markers such







Figure 1. (A) Whole-mount section shows the location of the tumors in the ampulla of Vater (hematoxylin & eosin [H&E], 1×). C = common
bile duct; P = pancreas; D = duodenum; T = tumors in the ampulla of Vater. (B) Poorly differentiated endocrine carcinoma. The tumor has
infiltrated the submucosa of the duodenal papilla. The tumor cells are arranged in an organoid pattern with focal glandular differentiation
(H&E, 40×). (C) Conventional adenocarcinoma in the ampulla of Vater. The tumor cells are arranged in a glandular pattern with projecting
papillary fronds and tufts (H&E, 100×). (D) Collision site shows abrupt morphologic alterations between poorly differentiated endocrine
carcinoma and conventional adenocarcinoma.
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a high Ki-67 labeling index. We also evaluated expres-
sion of oncogenic markers, such as CD117, cycline D1
and p53, in the poorly differentiated endocrine carci-
noma and conventional ductal adenocarcinoma. Both
tumors were negative for all the oncogenic markers.
Discussion
According to the WHO classification published in
2000, neuroendocrine neoplasms as compared to
their pulmonary counterparts can be categorized into
well-differentiated endocrine tumor (carcinoid), well-
differentiated endocrine carcinoma (atypical carci-
noid), and poorly differentiated endocrine carcinoma
(small cell carcinoma and large cell neuroendocrine
carcinoma).4
In the periampullary area, adenocarcinoma com-
prises more than 90% of all malignancies. Neuroendo-
crine tumors are rare in this area, and the majority of
them are well-differentiated endocrine tumors (carci-
noids). In the literature reviewed, von Recklinghausen’s
disease or multiple endocrine neoplasia I (MEN I) is
commonly associated with endocrine neoplasms of
the duodenal papilla.5 Patients with carcinoids have a
better prognosis than those with conventional adeno-
carcinoma. Poorly differentiated endocrine carcinoma
(small cell carcinoma and large cell neuroendocrine
carcinoma) is extremely rare and only reported in case
studies and small series.6–10 Several surgical procedures
are elaborated to approach such tumors.11
Our case can also be classified as large cell neu-
roendocrine carcinoma according to a 3-grade scheme
for pulmonary neuroendocrine tumors proposed by
Travis.12 Based on several case reports and a small series
study, large cell neuroendocrine carcinomas occur in
patients in their 5th decade of life and beyond. Com-
mon symptoms and signs are related to obstructive jaun-
dice, such as icterus, anorexia, tea-colored urine, and
skin itching. Metastases to lymph nodes are common,
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Figure 2. The tumor cells of the poorly differentiated endocrine carcinoma are immunoreactive for: (A) cytokeratin AE1/AE3; (B) CD56;
(C) chromogranin; (D) synaptophysin.
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and the liver is the predominant organ of tumor me-
tastasis. The prognosis is dismal and most patients die
of metastatic disease within 2 years (Table 1).6–10,13
Coexistence of adenocarcinoma and neuroen-
docrine tumors has been reported by a few case stud-
ies. In the literature reviewed, only 6 cases of coexisting
carcinoid and adenocarcinoma in the periampullary
area were found.14–16 In a small series study conducted
by Nassar et al, half of the patients with high-grade neu-
roendocrine carcinoma in the ampulla of Vater were
associated with adenoma, some with high-grade dys-
plasia.10 After a meticulous search of the PubMed
database with key words such as “neuroendocrine car-
cinoma”, “adenocarcinoma”, and “ampulla of Vater”,
we believe that our case is the first case of a large cell
neuroendocrine carcinoma colliding with invasive
adenocarcinoma in the ampulla of Vater. In our case,
distinct histologic and immunophenotypic features,
different epicenters of the tumors, and an abrupt
transitional area between the tumors exclude the 
possibility of a compound or mixed tumor. A com-
mon origin for neuroendocrine carcinoma and con-
ventional adenocarcinoma has been proposed and
subsequent genetic events may give rise to further dif-
ferentiation. Expression of several oncogenic markers,
such as p53, p27, Rb, Smad4 and CD117, has been
demonstrated in some periampullary neuroendocrine
carcinomas and ductal adenocarcinomas. In our case,
both tumors were negative for p53, CD177 and cycline
D1, which may suggest that other mechanisms were
involved in the pathogenesis and support the idea of
inconsistent expression of oncogenic markers in these
tumors. That is, not all neuroendocrine carcinomas or
adenocarcinomas are immunoreactive for a specific
marker. Due to the rarity of cases, additional compar-
ative studies of such combined tumors are required to
understand their pathogenesis and relationship.
In conclusion, we presented a case of coexisting large
cell neuroendocrine carcinoma and conventional ade-
nocarcinoma in the ampulla of Vater. Such a phenom-
enon has also been reported by a few case reports and
a small series study. Further investigations are required
to determine the pathogenesis of the phenomenon.
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